Clinical Trial Update: Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating donepezil for mild cognitive impairment in Parkinson's disease is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Parkinson Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Parkinson Disease, Mild Cognitive Impairment | Phase 2 | Status: UNKNOWN